MarketersMEDIA / Newsroom / Retinal Disease Therapeutics Market: 2019 Worldwide Opportunities, Market Share, Key Players and Competitive Landscape

Retinal Disease Therapeutics Market: 2019 Worldwide Opportunities, Market Share, Key Players and Competitive Landscape

Share This Press Release

Global Retinal Disease Therapeutics Market to Rise at 8.6%, Facilitated by Increasing Regulatory Approvals for Favoring Drugs

— The global retinal disease therapeutics market is likely to expand at an impressive rate driven by recent government participation towards prevention and control of retinal diseases. According to a report published by Fortune Business Insights, titled “Retinal Disease Therapeutics: Global Market Analysis, Insights, and Forecast, 2019-2026,” the market is likely to reach US$ 21,318.0 Mn by the end of 2026. The market was valued at US$ 11,044.2 Mn in 2018 and is likely to witness a CAGR of 8.6% in the forecast period.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/retinal-disease-therapeutics-market-100311

F. Hoffmann-La Roche AG’s ‘Lucentis’ is Gaining Increasing Popularity

The global retinal disease therapeutics market is consolidated in nature, with only a handful of market players accounting for maximum share of the market. With consolidation, it is becoming increasingly difficult for newer market entrants to establish a stronghold or derive immediate success. Therefore the global market is boosted by products and concepts introduced by existing companies. One such instance of this development is the “Lucentis” therapy, put forward by F. Hoffmann-La Roche AG.

Lucentis was introduced with an aim of providing therapeutic advice and development of products for patients suffering from chronic disease. In 2017, the Food and Drug Administration (FDA) approved Lucentis for diabetic retinopathy. The diabetic retinopathy is a severe kind of disorder that has accounted for majority of cases of blindness in the US.

By Geography:
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, Rest of Latin America)
· Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa)

North America to Emerge Dominant in the Forecast Period

The increasing government investment towards research and development of retinal disease drugs and diagnostic devices is enabling growth in the retinal diseases therapeutics market in North America. North America has emerged dominant in the global retinal disease therapeutics market in recent years.

The retinal disease therapeutics market in North America was valued at US$ 4056.5Mn in 2018 and is likely to increase in the coming years. Improved health infrastructures, increasing patient pool, and favourable health reimbursement policies are some of the factors that are likely to boost the regional market in the forthcoming years. High prevalence of retinal diseases in Asia Pacific is a major reason, why this region is estimated to rise with the highest CAGR in the forecast period.

Get Sample PDF Brochure@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/retinal-disease-therapeutics-market-100311

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis: Leading companies that are operating in the global retinal disease therapeutics market are Merck & Co., Inc., Novartis AG, Allergan plc, F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd.

TABLE OF CONTENT:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities

4. Key Insights
4.1 Recent industry developments such as mergers & acquisitions
4.2 Regulatory scenario for key countries
4.3 Prevalence of Key Retinal Diseases, in Major Countries
4.4 Pipeline Analysis
4.5 Patent Snapshot

Contact Info:
Name: Mr. Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights Pvt. Ltd.
Website: https://www.fortunebusinessinsights.com/

Source URL: https://marketersmedia.com/retinal-disease-therapeutics-market-2019-worldwide-opportunities-market-share-key-players-and-competitive-landscape/88909090

Source: MarketersMedia

Release ID: 88909090

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).